400 Participants Needed

Meditation Program for Cancer Patients and Caregivers

KM
Overseen ByKathrin Milbury, MD,PHD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: M.D. Anderson Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on supportive care programs, so it's unlikely that medication changes are required, but you should confirm with the trial coordinators.

What data supports the effectiveness of the treatment Meditation Program, Mindfulness Meditation, Meditation Therapy, Psycho-Spiritual Intervention for cancer patients?

Research shows that mindfulness meditation programs can help cancer patients by reducing mood disturbances and stress symptoms, and improving quality of life and coping skills. These benefits have been observed in various studies, including those involving breast cancer patients, and can last for several months after the program ends.12345

Is mindfulness meditation safe for cancer patients and caregivers?

Mindfulness meditation programs, like Mindfulness-Based Stress Reduction (MBSR), have been studied in cancer patients and generally show benefits in reducing stress and mood disturbances without reported safety concerns, indicating they are generally safe for human use.23678

How is the Meditation Program treatment different from other treatments for cancer patients?

The Meditation Program is unique because it focuses on improving the psychological and emotional well-being of cancer patients and their caregivers through mindfulness and meditation, rather than directly targeting the cancer itself. This approach helps reduce stress, anxiety, and depression, and improves sleep and mood, which are common challenges faced by cancer patients.1391011

What is the purpose of this trial?

The goal of this behavioral research study is to learn about the effects of two different supportive care programs on patients' and their family caregivers' psychological wellbeing and overall quality of life.

Research Team

KM

Kathrin Milbury, MD,PHD

Principal Investigator

MD Anderson

Eligibility Criteria

This trial is for adults with stage IV breast, thoracic, gastrointestinal, gynecological, or genitourinary cancer who've had no disease progression for at least 3 months. They must have a caregiver willing to join the study and both should be able to understand English or Spanish. Participants need an ECOG performance status of ≤2 and a distress score ≥4.

Inclusion Criteria

Both patient and caregiver must be able to provide informed consent
I am able to care for myself and perform daily activities.
Have a family caregiver willing to participate
See 3 more

Exclusion Criteria

Pregnant patients
I am under 18 years old.
Have cognitive deficits that would impede the completion of self-report instruments as deemed by their attending oncologist

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Behavioral Intervention

Participants will take part in a discussion program with 4 sessions over 4 weeks

4 weeks
4 sessions (virtual)

Attention Control

Participants will take part in a meditation program with up to 4 sessions

4 weeks
4 sessions (virtual)

Follow-up

Participants are monitored for psychological wellbeing and quality of life

1 year

Treatment Details

Interventions

  • Meditation Program
Trial Overview The study examines the impact of two different supportive care programs on psychological wellbeing and quality of life in patients with advanced cancer and their caregivers. It involves a meditation program designed to help manage psycho-spiritual aspects related to cancer.
Participant Groups
3Treatment groups
Experimental Treatment
Group I: Usual CareExperimental Treatment1 Intervention
All participants will receive cancer treatment per usual care (UC).
Group II: Behavioral Intervention (FFM Program)Experimental Treatment1 Intervention
Participants will take part in a discussion program. Participants will be asked to complete 4 discussion sessions with a trained counselor over a course of a 4 week period. Participants should attend each session together as a family.
Group III: Attention ControlExperimental Treatment1 Intervention
Participants will take part in a meditation program. As part of this program, participants will complete up to 4 meditation sessions with a trained counselor. Participants should attend each session together as a family. All sessions will be online by videoconference using Zoom.

Meditation Program is already approved in United States, European Union, Canada for the following indications:

🇺🇸
Approved in United States as Meditation Program for:
  • Anxiety
  • Depression
  • Stress Management
  • Pain Management
  • Quality of Life Improvement
🇪🇺
Approved in European Union as Mindfulness Meditation for:
  • Anxiety Disorders
  • Depressive Disorders
  • Chronic Pain Management
  • Stress Reduction
🇨🇦
Approved in Canada as Meditation Therapy for:
  • Mental Health Support
  • Palliative Care
  • Symptom Management
  • Well-being Enhancement

Find a Clinic Near You

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials
3,107
Recruited
1,813,000+

Findings from Research

Five studies on meditation interventions for cancer patients showed that while the design did not isolate meditation's effects, four of them reported significant improvements in symptoms of depression and anxiety.
There is a growing recognition that meditation may enhance spiritual well-being, which could positively impact the quality of life for cancer patients, but more rigorously designed studies are needed to confirm these effects.
[Does meditation improve the quality of life for patients living with cancer?].Lamanque, P., Daneault, S.[2018]
Participation in a 7-week mindfulness meditation program significantly reduced mood disturbance and stress symptoms in 89 cancer outpatients, with improvements lasting for at least 6 months after the program ended.
Higher initial mood disturbance and more daily meditation practice were linked to greater improvements, indicating that mindfulness meditation can be a beneficial intervention for managing stress in cancer patients across various demographics.
The effects of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients: 6-month follow-up.Carlson, LE., Ursuliak, Z., Goodey, E., et al.[2019]
Mindfulness-based stress reduction (MBSR) shows promising psychological benefits for cancer patients, as indicated by various instruments measuring its impact, although the effectiveness of these instruments varies.
The review highlights the need for more rigorous intervention studies on MBSR in cancer care to better understand its benefits and to refine the tools used to measure its effects.
Measuring the psychological impact of mindfulness meditation on health among patients with cancer: a literature review.Matchim, Y., Armer, JM.[2007]

References

[Does meditation improve the quality of life for patients living with cancer?]. [2018]
The effects of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients: 6-month follow-up. [2019]
Measuring the psychological impact of mindfulness meditation on health among patients with cancer: a literature review. [2007]
The effects of mindfulness-based stress reduction on psychosocial outcomes and quality of life in early-stage breast cancer patients: a randomized trial. [2022]
[Effects of Mindfulness Meditation program on perceived stress, ways of coping, and stress response in breast cancer patients]. [2015]
Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients. [2018]
A non-randomized comparison of mindfulness-based stress reduction and healing arts programs for facilitating post-traumatic growth and spirituality in cancer outpatients. [2022]
Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. [2023]
Meditation as a complementary therapy in cancer. [2019]
[Effectiveness of mindfulness-based cancer recovery (MBCR) program among Hungarian cancer patients]. [2017]
11.United Statespubmed.ncbi.nlm.nih.gov
A pilot study evaluating the effect of mindfulness-based stress reduction on psychological status, physical status, salivary cortisol, and interleukin-6 among advanced-stage cancer patients and their caregivers. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security